CA-XX-NETWORK
25.1.2022 16:32:05 CET | Business Wire | Press release
The world’s first quantum-resistant messaging app, xx messenger , launched on the xx network today. xx messenger allows users to communicate in real time through hundreds of decentralized nodes operating worldwide. The app is available for download on IOS and Android, features group chat as well as photo and audio sharing, and designed for easy use and switching to from legacy messaging apps.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220125005773/en/
Unlike existing messaging apps, xx messenger uses quantum-resistant cryptography to protect message content from decoding and cMix software to obfuscate or shred metadata—information about who sends, when they send, where they send from, and who receives. Randomly selected teams of xx nodes encrypt anonymity sets of 1,000 messages, which are then repeatedly shuffled and have also been encrypted using quantum-resistant cryptography. Information that links senders and receivers is destroyed, preventing third parties from tracking intimate details about the patterns and structure of our lives.
Centralized service providers now surveil and profile the majority of digital users. Our personal information has been marketed, auctioned, and monetized in an ever-increasingly exploitative manner to advertisers and political groups, which use it to micro-target and manipulate consumers or voters. Decentralized platforms offer a unique opportunity to weave the privacy principles of the early internet back into the fabric of the emerging web3 ecosystem. xx messenger is dedicated to protecting and strengthening inalienable privacy rights at the dawn of web3.
-
Existing Message Encryption is not Quantum Resistant: There is general agreement that, within the relevant timeframe, quantum computers will be able to decode communications that have been encrypted using legacy crypto. At that point, messages sent on all other existing messengers, even those with “strong end-to-end encryption,” will be easily retroactively decoded and analyzed by artificial intelligence. Only what has been said using xx messenger will remain private.
-
Only xx Offers Metadata Shredding: All existing mainstream messengers can capture and potentially exploit metadata. Metadata shredding works by sending messages through randomly chosen xx network nodes around the world. Each node changes the order and the encryption before forwarding and then erases any record of what it has done. Each part of the metadata about who is talking to whom is thereby destroyed before any of the parts can even be assembled to trace.
- Full xx Decentralization: Every message sent on xx messenger travels through five nodes chosen at random from hundreds of xx nodes around the world. There is no centralized entity for governments to coerce, no company to insert spyware or reveal data from its database. The xx network supporting the xx messenger is a distributed, decentralized blockchain, now in mainnet, and is operated on transparent software run by more than 350 independently owned nodes in more than 80 countries. The xx messenger App, is truly a decentralized App (dApp), which means that it operates on a decentralized blockchain autonomously through smart contracts.
The pioneering team behind the creation of the xx messenger developed early practical, anonymous, and verifiable cryptographic systems and is led by renowned cryptographer David Chaum, who proposed and deployed digital currencies, mix networks, permissionless cryptographic solutions, and verifiable voting systems starting in the 1980s.
“Recent privacy concerns have sensitized the public to problems with control of personal information by centralized entities like Facebook. Realizing that their information is being misused by corporate entities, people are now trying to understand how to use cryptography and smartphones to protect themselves and change society in beneficial ways; xx messenger is securely decentralizing private communication the way Bitcoin decentralized finance. Let’s do this right: let’s take control of our own information– and our destiny.” said David Chaum, inventor of electronic cash and founder of xx network.
The xx messenger is available for download on Android and Apple app stores. Please follow us on Twitter and join our Telegram and Discord .
About xx network
xx network is a new type of platform, offering a protected digital sphere through which its users can share ideas and exchange value in a secure and private way. The xx network blockchain relies on a novel quantum-secure consensus algorithm that efficiently achieves linear authenticator complexity and single-block finality, ensuring scaleable consensus-based operations. The network was built by teams led by David Chaum, the Godfather of cryptocurrency.
For more information, please visit https://xx.network/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220125005773/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
Seoul Viosys Eyes the $60 Billion AI Data Center Optical Communication Market with Opto Semiconductors27.4.2026 15:00:00 CEST | Press release
Joint Development Talks with Global Optical Communications companiesExpanding Partnerships to Provide Total Transceiver Solution1,800 Patents Secured for High-Performance Optical Communications Seoul Viosys (KOSDAQ: 092190), a company specializing in opto-semiconductor devices, is accelerating its entry into the next-generation photonics market supported by its proprietary “No-wire” and “No-package” fundamental patents—essential technologies for micrometer (μm)-scale miniaturization of opto-semiconductors—as well as its competitiveness in VCSEL technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426926495/en/ Seoul Viosys Optoelectronic Semiconductor Structure Subject to a Permanent U.S. Injunction in February 2026, Covering Similar Products and Employees (Image: Seoul Viosys) As the rapid expansion of AI drives a paradigm shift in data centers from copper-based to optical-based architectures, the company is streng
vVARDIS Announces Investment from Apollo—Achieves Unicorn Status27.4.2026 14:51:00 CEST | Press release
Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. vVARDIS is redefining the treatment of cavities through its Curodont™ technology, the first and only commercially available non-invasive peptide-containing formulati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
